Delivery Order SPE2DB24D6041-SPE2DB25FKBQN

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,612.92 firm-fixed-price contract is for the delivery of the medication LO LOESTRIN FE 1-10 TABLET 28S, with a performance period ending on June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $3,746.18 for the medical product "LO LOESTRIN FE 1-10 TABLET 28S". The contract has an ultimate completion date of November 14, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $13,069.60, is for the delivery of the medication LO LOESTRIN FE 140S. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,427.28 firm-fixed-price contract is for the delivery of Lo Loestrin Fe 1-10 tablet 28s, a prescription contraceptive medication. The contract has an ultimate completion date of September 14, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,729.91 and a completion date of March 12, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract covers the supply of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,785.01, is a firm fixed-price delivery order for the medical product "LO LOESTRIN FE 1-10 TABLET 28S". The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.41 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a $5,149.80 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,204.58, is a delivery order for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract is a firm fixed-price, with an ultimate completion date of April 8, 2025. The award was made on April 7, 2025, and there was no set-aside designation used. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,112.26 Firm Fixed Price delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, with a completion date of February 26, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBQN
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,318.93, is a delivery order for the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price agreement.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/28/25, 9:46 AM